MedTrace Logo

Endoscopic Diagnosis and Treatment of Acute Nonvariceal Upper Gastrointestinal Bleeding

NCT04895904 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 3200

Last updated 2021-05-20

No results posted yet for this study

Summary

Acute nonvariceal upper gastrointestinal bleeding (ANVUGIB) is a common critical disease in gastroenterology. Due to the development of modern medical technology, the incidence rate of ANVUGIB has been decreasing in recent years, but its mortality within 30 days is still 11%. Endoscopic hemostasis and drug therapy are the first choice for the treatment of ANVUGIB. After endoscopic hemostasis, it is very important to treat peptic ulcer bleeding with strong acid suppression therapy to maintain gastric pH above 6.0. This study is to study the effect of endoscopic and drug treatment of ANVUGIB.

Conditions

  • Acute Upper Gastrointestinal Non Variceal Hemorrhage

Interventions

OTHER

No intervention

Our study is an observational study and the main purpose of our study is to observe the efficacy of endoscopic hemostasis and drug therapy

Sponsors & Collaborators

  • The First Affiliated Hospital of Nanchang University

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-09-01
Primary Completion
2021-02-28
Completion
2021-02-28

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04895904 on ClinicalTrials.gov